BI-3406

Item number	Size	Delivery time	Price
TGM-T12979-1mg	1 mg	7 - 10 business days*	67.00€
TGM-T12979-5mg	5 mg	7 - 10 business days*	161.00€
TGM-T12979-1mL	1 ml	7 - 10 business days*	176.00€
TGM-T12979-10mg	10 mg	7 - 10 business days*	261.00€
TGM-T12979-25mg	25 mg	7 - 10 business days*	486.00€
TGM-T12979-50mg	50 mg	7 - 10 business days*	698.00€
TGM-T12979-100mg	100 mg	7 - 10 business days*	966.00€
TGM-T12979-500mg	500 mg	7 - 10 business days*	1,932.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: BI-3406 is an orally active, highly potent and selective between KRAS and Son of... more

Close menu

Product information "BI-3406"

Description: BI-3406 is an orally active, highly potent and selective between KRAS and Son of Sevenless 1 (SOS1) interaction inhibitor(IC50 : 6 nM),with anticancer activity. Target: Ras, p38 MAPK, MAPK. Smiles: COc1cc2nc(C)nc(N[C@H](C)c3cc(N)cc(c3)C(F)(F)F)c2cc1O[C@H]1CCOC1. References: Marco H Hofmann, et al. Abstract PL06-01: Discovery of BI-3406: A potent and selective SOS1::KRAS inhibitor opens a new approach for treating KRAS-driven tumors. December 2019.

Supplier:	TargetMol
Supplier-Nr:	T12979

Properties

Application:	The K-Ras-SOS1 protein-protein interaction inhibitor
MW:	462.46 D
Formula:	C23H25F3N4O3

Database Information

CAS :	2230836-55-0\| Matching products
KEGG ID :	K07827 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "BI-3406"

Write a review